Molecular Pharmacology

Research Frontiers in Phosphoinositide 3 Kinase Isoform Selectivity Pharmacology

Design of PI3K p110 isoform-selective inhibitors achieving cell-type specific AKT pathway modulation with improved tolerability in cancer immunotherapy.

All Molecular Pharmacology PhD categories